461
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Intraarticular Injection of Infliximab-Loaded Thermosensitive Hydrogel Alleviates Pain and Protects Cartilage in Rheumatoid Arthritis

, , , , &
Pages 3315-3329 | Published online: 07 Dec 2020

References

  • Taylor PC, Keystone EC, van der Heijde D, et al. Baricitinib versus placebo or adalimumab in rheumatoid arthritis. N Engl J Med. 2017;376(7):652–662. doi:10.1056/NEJMoa1608345
  • Yousri NA, Bayoumy K, Elhaq WG, et al. Large scale metabolic profiling identifies novel steroids linked to rheumatoid arthritis. Sci Rep. 2017;7(1):9137.
  • Vande Walle L, Van Opdenbosch N, Jacques P, et al. Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis. Nature. 2014;512(7512):69–73. doi:10.1038/nature13322
  • Zhang A, Lee YC. Mechanisms for joint pain in rheumatoid arthritis (RA): from cytokines to central sensitization. Cur Osteoporosis Rep. 2018;16(5):603–610. doi:10.1007/s11914-018-0473-5
  • Krock E, Jurczak A, Svensson CI. Pain pathogenesis in rheumatoid arthritis-what have we learned from animal models? Pain. 2018;159(Suppl 1):S98–S109.
  • Doan T, Massarotti E. Rheumatoid arthritis: an overview of new and emerging therapies. J Clin Pharmacol. 2005;45(7):751–762.
  • Fang G, Zhang Q, Pang Y, Thu HE, Hussain Z. Nanomedicines for improved targetability to inflamed synovium for treatment of rheumatoid arthritis: multi-functionalization as an emerging strategy to optimize therapeutic efficacy. J Control Release. 2019;303:181–208.
  • Lu YC, Chuang CH, Chuang KH, et al. Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy. PLoS Biol. 2019;17(6):e3000286.
  • Yang X, Du H, Zhai G. Progress in intra-articular drug delivery systems for osteoarthritis. Curr Drug Targets. 2014;15(9):888–900.
  • Edwards SHR. Intra-articular drug delivery: the challenge to extend drug residence time within the joint. Veterinary J. 2011;190(1):15–21. doi:10.1016/j.tvjl.2010.09.019
  • Brown S, Kumar S, Sharma B. Intra-articular targeting of nanomaterials for the treatment of osteoarthritis. Acta Biomater. 2019;93:239–257. doi:10.1016/j.actbio.2019.03.010
  • Mertz N, Ostergaard J, Yaghmur A, Larsen SW. Transport characteristics in a novel in vitro release model for testing the performance of intra-articular injectables. Int J Pharm. 2019;566:445–453. doi:10.1016/j.ijpharm.2019.04.083
  • Badri W, Miladi K, Nazari QA, Greige-Gerges H, Fessi H, Elaissari A. Encapsulation of NSAIDs for inflammation management: overview, progress, challenges and prospects. Int J Pharm. 2016;515(1–2):757–773. doi:10.1016/j.ijpharm.2016.11.002
  • Jung Y-S, Park W, Park H, Lee D-K, Na K. Thermo-sensitive injectable hydrogel based on the physical mixing of hyaluronic acid and Pluronic F-127 for sustained NSAID delivery. Carbohydr Polym. 2017;156:403–408. doi:10.1016/j.carbpol.2016.08.068
  • Li Y, Cao J, Han S, et al. ECM based injectable thermo-sensitive hydrogel on the recovery of injured cartilage induced by osteoarthritis. Artif Cells, Nanomed Biotechnol. 2018;46(sup2):152–160. doi:10.1080/21691401.2018.1452752
  • Kim T, Seol DR, Hahm S-C, et al. Analgesic effect of intra-articular injection of temperature-responsive hydrogel containing bupivacaine on osteoarthritic pain in rats. Biomed Res Int. 2015;2015:812949. doi:10.1155/2015/812949
  • Kim M, Hwang Y, Tae G. The enhanced anti-tissue adhesive effect of injectable pluronic-HA hydrogel by poly(γ-glutamic acid). Int J Biol Macromol. 2016;93(Pt B):1603–1611. doi:10.1016/j.ijbiomac.2016.02.064
  • Oh SH, Kang JG, Lee JH. Co-micellized pluronic mixture with thermo-sensitivity and residence stability as an injectable tissue adhesion barrier hydrogel. J Biom Mater Res Part B. 2018;106(1):172–182. doi:10.1002/jbm.b.33824
  • Seo J, Park SH, Kim MJ, et al. Injectable click-crosslinked hyaluronic acid depot to prolong therapeutic activity in articular joints affected by rheumatoid arthritis. ACS Appl Mater Interfaces. 2019;11(28):24984–24998. doi:10.1021/acsami.9b04979
  • Silva CR, Babo PS, Gulino M, et al. Injectable and tunable hyaluronic acid hydrogels releasing chemotactic and angiogenic growth factors for endodontic regeneration. Acta Biomater. 2018;77:155–171. doi:10.1016/j.actbio.2018.07.035
  • Segal B, Rhodus NL, Patel K. Tumor necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis. Oral Surgery. 2008;106(6):778–787. doi:10.1016/j.tripleo.2008.07.025
  • Fong Y, Chen C-H, Chen J-P. Intratumoral delivery of doxorubicin on folate-conjugated graphene oxide by in-situ forming thermo-sensitive hydrogel for breast cancer therapy. Nanomaterials. 2017;7(11):11. doi:10.3390/nano7110388
  • Micheli M, Bozdag B, Akgul A, et al. Pain relieving effect of-NSAIDs-CAIs hybrid molecules: systemic and intra-articular treatments against rheumatoid arthritis. Int J Mol Sci. 2019;20(8):8. doi:10.3390/ijms20081923
  • Tarafder S, Bose BS. Polycaprolactone-coated 3D printed tricalcium phosphate scaffolds for bone tissue engineering: in vitro alendronate release behavior and local delivery effect on in vivo osteogenesis. ACS Appl Mater Interfaces. 2014;6(13):9955–9965. doi:10.1021/am501048n
  • Posadowska U, Parizek M, Filova E, et al. Injectable nanoparticle-loaded hydrogel system for local delivery of sodium alendronate. Int J Pharmaceut. 2015;485(1–2):31–40. doi:10.1016/j.ijpharm.2015.03.003
  • Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–2581. doi:10.1002/art.27584
  • Ayhan E. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop. 2014;5(3):351–361. doi:10.5312/wjo.v5.i3.351
  • Gouveia VM, Lopes-de-Araujo J, Costa Lima SA, Nunes C, Reis S. Hyaluronic acid-conjugated pH-sensitive liposomes for targeted delivery of prednisolone on rheumatoid arthritis therapy. Nanomedicine. 2018;13(9):1037–1049. doi:10.2217/nnm-2017-0377
  • Yang H, Liu Z, Song Y, Hu C. Hyaluronic acid-functionalized bilosomes for targeted delivery of tripterine to inflamed area with enhancive therapy on arthritis. Drug Deliv. 2019;26(1):820–830. doi:10.1080/10717544.2019.1636423
  • Yu C, Li X, Hou Y, et al. Hyaluronic acid coated acid-sensitive nanoparticles for targeted therapy of adjuvant-induced arthritis in rats. Molecules. 2019;24:1.
  • Guidolin D, Franceschi F. Viscosupplementation with high molecular weight native hyaluronan. Focus on a 1500-2000 KDa fraction (Hyalubrix(R)). Eur Rev Med Pharmacol Sci. 2014;18(21):3326–3338.
  • Boyden SD, Hossain IN, Wohlfahrt A, Lee YC. Non-inflammatory causes of pain in patients with rheumatoid arthritis. Curr Rheumatol Rep. 2016;18(6):30. doi:10.1007/s11926-016-0581-0
  • Meeus M, Vervisch S, De Clerck LS, Moorkens G, Hans G, Nijs J. Central sensitization in patients with rheumatoid arthritis: a systematic literature review. Semin Arthritis Rheum. 2012;41(4):556–567. doi:10.1016/j.semarthrit.2011.08.001
  • Pinho-Ribeiro FA, Verri WA, Chiu IM. Nociceptor sensory neuron–immune interactions in pain and inflammation. Trends Immunol. 2017;38(1):5–19. doi:10.1016/j.it.2016.10.001
  • Schaible H-G. Nociceptive neurons detect cytokines in arthritis. Arthritis Res Ther. 2014;16(5):470. doi:10.1186/s13075-014-0470-8
  • Richter F, Natura G, Loser S, Schmidt K, Viisanen H, Schaible H-G. Tumor necrosis factor causes persistent sensitization of joint nociceptors to mechanical stimuli in rats. Arthritis Rheum. 2010;62(12):3806–3814. doi:10.1002/art.27715
  • Brenn D, Richter F, Schaible H-G. Sensitization of unmyelinated sensory fibers of the joint nerve to mechanical stimuli by interleukin-6 in the rat: an inflammatory mechanism of joint pain. Arthritis Rheum. 2007;56(1):351–359. doi:10.1002/art.22282
  • Richter F, Natura G, Ebbinghaus M, et al. Interleukin-17 sensitizes joint nociceptors to mechanical stimuli and contributes to arthritic pain through neuronal interleukin-17 receptors in rodents. Arthritis Rheum. 2012;64(12):4125–4134. doi:10.1002/art.37695
  • Ebbinghaus M, Uhlig B, Richter F, et al. The role of interleukin-1β in arthritic pain: main involvement in thermal, but not mechanical, hyperalgesia in rat antigen-induced arthritis. Arthritis Rheum. 2012;64(12):3897–3907. doi:10.1002/art.34675
  • Zrubka Z, Gulacsi L, Brodszky V, et al. Long-term efficacy and cost-effectiveness of infliximab as first-line treatment in rheumatoid arthritis: systematic review and meta-analysis. Expert Rev Pharmacoecon Outcomes Res. 2019;19(5):537–549. doi:10.1080/14737167.2019.1647104
  • Atzeni F, Sarzi-Puttini P, Botsios C, et al. Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry. Autoimmun Rev. 2011;190(1):225–229. doi:10.1016/j.autrev.2012.06.008
  • Isgren A, Forslind K, Erlandsson M, et al. High survivin levels predict poor clinical response to infliximab treatment in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2018;106(1):652–657. doi:10.1016/j.semarthrit.2011.08.005
  • Zhao Y, Wang Z, Jiang Y, et al. Biomimetic composite scaffolds to manipulate stem cells for aiding rheumatoid arthritis management. Adv Funct Mater. 2019;1807860.
  • Kasama T, Isozaki T, Takahashi R, Miwa Y. Clinical effects of tocilizumab on cytokines and immunological factors in patients with rheumatoid arthritis. Int Immunopharmacol. 2016;35:301–306.
  • Wang P, Tao JH, Pan HF. Probiotic bacteria: a viable adjuvant therapy for relieving symptoms of rheumatoid arthritis. Inflammopharmacology. 2016;24(5):189–196.
  • Ansboro S, Roelofs AJ, De Bari C. Mesenchymal stem cells for the management of rheumatoid arthritis: immune modulation, repair or both? Curr Opin Rheumatol. 2017;29(2):201–207.
  • Li C, Li H, Wang Q, et al. pH-sensitive polymeric micelles for targeted delivery to inflamed joints. J Control Release. 2017;246:133–141.
  • Kotake S, Nanke Y. Effect of TNFalpha on osteoblastogenesis from mesenchymal stem cells. Biochim Biophys Acta. 2014;1840(3):1209–1213.
  • Su CM, Hu SL, Sun Y, et al. Myostatin induces tumor necrosis factor-alpha expression in rheumatoid arthritis synovial fibroblasts through the PI3K-Akt signaling pathway. J Cell Physiol. 2019;234(6):9793–9801.
  • Goodman SM, Menon I, Christos PJ, Smethurst R, Bykerk VP. Management of perioperative tumour necrosis factor alpha inhibitors in rheumatoid arthritis patients undergoing arthroplasty: a systematic review and meta-analysis. Rheumatology. 2016;55(3):573–582.
  • Papadaki HA, Kritikos HD, Gemetzi C, et al. Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect. Blood. 2002;99(5):1610–1619.